BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10147146)

  • 1. Compliance with therapy for ulcer disease: clinical experience and review of the literature.
    Ferrana M; DiMario F; Battaglia G; Vianello F; Salandin S; Bo ND; Pilotto A; Savarino V; Mela GS; Vigneri S
    Adv Ther; 1994; 11(2):52-7. PubMed ID: 10147146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roxatidine in duodenal ulcer.
    Habibullah CM; Habeeb MA; Singh SP
    J Postgrad Med; 1995; 41(3):64-5. PubMed ID: 10707717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
    Lai KC; Hui WM; Wong WM; Wong BC; Hu WH; Ching CK; Lam SK
    Am J Gastroenterol; 2000 Sep; 95(9):2225-32. PubMed ID: 11007222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of duodenal ulcer with a single evening dose of ranitidine].
    Nardini A; Ricci F
    Clin Ter; 1986 Jul; 118(2):115-8. PubMed ID: 3742978
    [No Abstract]   [Full Text] [Related]  

  • 5. [Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori].
    Amendola M; Farias R; Katz J; Luna P; Ianella M; Musi A; Boerr L; Valero J; Kogan Z; Corti R
    Acta Gastroenterol Latinoam; 1999; 29(2):47-50. PubMed ID: 10491714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up.
    Bytzer P; Teglbjaerg PS;
    Am J Gastroenterol; 2001 May; 96(5):1409-16. PubMed ID: 11374675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of antibiotic therapy on bleeding from duodenal ulcer.
    Sonnenberg A; Olson CA; Zhang J
    Am J Gastroenterol; 1999 Apr; 94(4):950-4. PubMed ID: 10201462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
    Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
    Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of quadruple therapy in the eradication of Helicobacter pylori and prevention of recurrent duodenal ulcer].
    Ocaña Andrade E; Espinosa Soberanes JA; Mares Zambrano MA; Rosete Reyes A
    Rev Gastroenterol Mex; 1998; 63(4):182-6. PubMed ID: 10319667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
    Cutler AF; Vakil N
    Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ranitidine in primary peptic ulcer in childhood complicated by acute hemorrhage].
    Cordone G; Venzano V; Ricci F; Buoncompagni A; Fasce L; Iester A
    Pediatr Med Chir; 1986; 8(1):85-8. PubMed ID: 3725618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nizatidine: a meta-analytical study].
    di Ciommo V; Ferrario F
    Clin Ter; 1993 Sep; 143(3):201-7. PubMed ID: 8222550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial.
    Fallone CA; Loo V; Joseph L; Barkun J; Kostyk R; Barkun AN
    Clin Invest Med; 1999 Oct; 22(5):185-94. PubMed ID: 10579057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies.
    Kate V; Ananthakrishnan N; Badrinath S
    Br J Surg; 2001 Aug; 88(8):1054-8. PubMed ID: 11488789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
    Cherniakevich SA; Babkova IV; Mikhalev AI
    Klin Med (Mosk); 2002; 80(9):52-4. PubMed ID: 12416227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.